A 12-week double-blind randomised controlled trial investigating the effect of dietary supplementation with 125 μg/d vitamin D in adults with asthma
Open Access
- 16 May 2024
- journal article
- research article
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 132 (6) , 738-749
Abstract
Vitamin D deficiency has previously been linked to higher rates of exacerbation and reduced lung function in asthmatics. Previous randomised controlled trials investigating the effect of vitamin D supplementation have mainly focused on children with asthma. Trials involving adults have typically used bolus dosing regimens, and the main outcomes have been patient-focused without investigating underlying inflammation. The present study aimed to conduct a 12-week placebo-controlled randomised controlled trials administering a daily 125 µg vitamin D3 supplement to adults with mild to moderate asthma. A total of 32 participants were randomised to receive either the 125 μg vitamin D3 supplement or an identical matching placebo. The primary outcome of the study was lung function measured by the ratio of FEV1:FVC (effect size 2·5) with secondary outcomes including asthma symptoms and inflammatory biomarkers. There was a small but statistically significant higher increase in the mean (±sd) ratio of FEV1:FVC from baseline to post-intervention in the vitamin D group (+0·05 ± 0·06) compared with the placebo group (+0·006 ± 0·04, P = 0·04). There was no effect of the intervention on asthma control test scores, or the inflammatory biomarkers measured. There was a moderate, significant association between baseline plasma 25(OH)D concentration and baseline plasma IL-10 (r = 0·527, P = 0·005) and TNF-α (r = −0·498. P = 0·008) concentrations. A daily vitamin D3 supplement led to slightly improved lung function in adult asthmatics and may be a useful adjunct to existing asthma control strategies, particularly for individuals with suboptimal vitamin D status.Keywords
This publication has 50 references indexed in Scilit:
- Long-term supplementation with 3200 to 4000 IU of vitamin D daily and adverse events: a systematic review and meta-analysis of randomized controlled trialsEuropean Journal of Nutrition, 2023
- Predictive role of IL-17A/IL-10 ratio in persistent asthmatic patients on vitamin D supplementImmunobiology, 2019
- A molecular simulation analysis of vitamin D targets interleukin 13 (IL13) as an alternative to mometasone in asthma3 Biotech, 2018
- Effect of alfacalcidol on the pulmonary function of adult asthmatic patients: A randomized trialAnnals of Allergy, Asthma & Immunology, 2017
- Vitamin D for the management of asthmaCochrane Database of Systematic Reviews, 2016
- The effects of vitamin D supplementation on airway functions in mild to moderate persistent asthmaAnnals of Allergy, Asthma & Immunology, 2014
- Interleukin-10: Cytokines in Anti-inflammation and Tolerance2013
- Vitamin D: modulator of the immune systemCurrent Opinion in Pharmacology, 2010
- Development of the asthma control testJournal of Allergy and Clinical Immunology, 2004
- Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthmaJournal of Allergy and Clinical Immunology, 1992